×
戻る Agenda
Panel Discussion
Session Chair(s)
Yuko Kojima, RPh
Sr. Executive Director, Eli Lilly Japan K.K., Japan
Rika Abe, RPh
Research Administrator, Office of the Fugaku Society 5.0 Initiative, RIKEN Center for Computational Science, Japan
Speaker(s)
Motonori Kimura
, Keio University Hospital, Japan
Takamasa Sakai
Assistant Professor, Drug Informatics, Faculty of Pharmacy, Meijo University, Meijo University, Japan
Keiko Akamatsu
, Eli Lilly Japan K.K., Japan
Wataru Kuga, PhD
Reviewer, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Shinya Takemoto, MSc
Group Manager, Safety Information Strategy Group, Risk Communication Department, Chugai Pharmaceutical Co., Ltd., Japan
Hiroki Nagahama, MS
Director, Japan Safety Risk Management Lead, Clinical Safety & Pharmacovigilance, GlaxoSmithKline K.K., Japan
Hideo Nakada, RPh
Deputy Associate Manager, Department of Hospital Pharmacy, Keio University, Japan